Valuation: GC Corp.

Market Cap 413B 311M 278M 257M 233M 436M 29.6B 443M 3.1B 1.23B 15.48B 1.17B 1.14B 49.01B P/E 2024
33.1x
P/E 2025 -10.5x
Enterprise Value 1,807B 1.36B 1.22B 1.13B 1.02B 1.91B 130B 1.94B 13.56B 5.36B 67.76B 5.11B 5B 215B EV / Sales 2024
0.83x
EV / Sales 2025 0.86x
Free-Float
43.96%
Yield 2024
2.89%
Yield 2025 1.88%
1 day-2.57%
1 week-5.90%
Current month-4.42%
1 month-3.71%
3 months-4.72%
6 months-36.83%
Current year-42.90%
1 week 9,090
Extreme 9090
9,780
1 month 8,990
Extreme 8990
10,150
Current year 8,630
Extreme 8630
18,010
1 year 8,630
Extreme 8630
18,010
3 years 8,630
Extreme 8630
18,490
5 years 8,630
Extreme 8630
30,850
10 years 8,630
Extreme 8630
56,300
Manager TitleAgeSince
Chief Executive Officer 52 2010-02-28
Chief Executive Officer 72 2010-03-24
Corporate Officer/Principal 43 -
Director TitleAgeSince
Chairman 72 2010-12-16
Director/Board Member 76 2009-02-28
Director/Board Member 52 2010-02-28
Date Insider Type Main position Quantity % Market Cap. Importance
4/25/25 Buy

Chief Executive Officer

1,334 0.0028%
4/25/25 Buy

Chief Executive Officer

3,191 0.0068%
4/25/25 Buy

Chief Executive Officer

6,748 0.0143%
Change 5-day change 1-year change 3-year change Capi.($)
-2.57%-5.90%-42.32%-31.76% 313M
+0.45%+3.13%+54.96%+125.16% 1,140B
+0.94%+4.93%+39.86%+78.72% 641B
+0.39%+1.44%+25.77%+97.48% 507B
+1.43%+4.31%+46.20%+67.12% 383B
-3.21%-2.10%+60.72%+33.22% 347B
-0.41%+2.64%+22.48%+49.82% 293B
+0.23%+3.66%+2.57%+23.69% 266B
+1.22%+4.63%+52.40%+64.85% 240B
+1.70%+3.67%+31.21%+102.15% 197B
Average -0.01%+2.12%+29.39%+61.05% 401.41B
Weighted average by Cap. +0.44%+2.98%+41.36%+83.79%

Financials

2024 2025
Net sales 2,205B 1.66B 1.49B 1.37B 1.24B 2.33B 158B 2.37B 16.54B 6.54B 82.68B 6.24B 6.1B 262B 2,451B 1.85B 1.65B 1.53B 1.38B 2.59B 176B 2.63B 18.39B 7.27B 91.93B 6.93B 6.79B 291B
Net income 24.03B 18.11M 16.19M 14.98M 13.56M 25.38M 1.72B 25.8M 180M 71.3M 901M 67.95M 66.5M 2.85B -69.51B -52.38M -46.84M -43.34M -39.24M -73.44M -4.98B -74.64M -522M -206M -2.61B -197M -192M -8.25B
Net Debt 1,042B 785M 702M 650M 588M 1.1B 74.71B 1.12B 7.82B 3.09B 39.08B 2.95B 2.88B 124B 1,394B 1.05B 939M 869M 787M 1.47B 99.95B 1.5B 10.46B 4.14B 52.28B 3.94B 3.86B 166B
Projected Income Statement - Annual - GC Corp.
Logo GC Corp.
Green Cross Holdings is a Korea-based holding company principally engaged in the manufacture and distribution of pharmaceuticals. The Company operates its business through five segments. The Pharmaceutical Manufacturing and Sale segment mainly manufactures and sells blood products, general pharmaceuticals, vaccines and over-the-counter (OTC) drugs. The Medical Service and System Development and Supply segment primarily provides healthcare services. The Diagnostic and Analysis segment mainly engages in blood diagnostics and genetic analysis business. The Leasing and Service Business segment is primarily involved in the real estate leasing and the management of affiliated group companies. The Other segment mainly operates livestock operation and other business.
Employees
142
Date Price Change Volume
26-10-26 ₩9,090.00 -2.57% 51,861
26-10-23 ₩9,330.00 -1.27% 29,002
26-10-22 ₩9,450.00 -1.77% 28,888
26-10-21 ₩9,620.00 +0.42% 25,741
26-10-20 ₩9,580.00 -0.83% 32,288
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
  1. Stock Market
  2. Stocks
  3. A005250 Stock